Cargando…
Long non‐coding RNA LOC100133669 promotes cell proliferation in oesophageal squamous cell carcinoma
OBJECTIVES: LOC100133669 is a lncRNA whose function during tumorigenesis remains unclear now. Thus, we aimed to explore its clinical significance and function in oesophageal squamous cell carcinoma (ESCC). MATERIALS AND METHODS: ISH was used to detect LOC100133669 expression in ESCC tissues. The ful...
Autores principales: | Guan, Zhuzhu, Wang, Yali, Wang, Yu, Liu, Xiaoxu, Wang, Yan, Zhang, Weimin, Chi, Xinming, Dong, Yan, Liu, Xuefeng, Shao, Shujuan, Zhan, Qimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162797/ https://www.ncbi.nlm.nih.gov/pubmed/32130753 http://dx.doi.org/10.1111/cpr.12750 |
Ejemplares similares
-
Long noncoding RNA PCAT1, a novel serum-based biomarker, enhances cell growth by sponging miR-326 in oesophageal squamous cell carcinoma
por: Huang, Lijie, et al.
Publicado: (2019) -
A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma
por: Wu, Mengjiao, et al.
Publicado: (2019) -
FAT1, a direct transcriptional target of E2F1, suppresses cell proliferation, migration and invasion in esophageal squamous cell carcinoma
por: Wang, Yu, et al.
Publicado: (2019) -
Corrigendum to “A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma” [EBioMedicine 41 (2019) 244–255]
por: Wu, Mengjiao, et al.
Publicado: (2019) -
Corrigendum to “A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma” [EBioMedicine 41 (2019) 244–255]
por: Wu, Mengjiao, et al.
Publicado: (2021)